• Greetings from Eli Cohen, Minister of Economy and Industry
• Greetings from Ruti Alon, Dr. Ora Dar and Dr. Nissim Darvish MIXiii Biomed 2019 Co-Chairs
• ACKNOWLEDGEMENTS
• Israel’s Life Science Industry Offers Unique Innovative Capabilities
  An interview with MIXiii BIOMED 2019 Conference Co-Chairs Ruti Alon, Dr. Ora Dar and Dr. Nissim Darvish
• Sharing the Risks in the Global Healthcare Revolution
  Israel Innovation Authority Senior Director Healthcare & Biotechnology Itai Kela (Ph.D., MBA) talks about the opportunities created for Israel by global trends in healthcare and biotech
• Israeli Biotech Offers Solutions to Dearth of New Drug Candidates
  Israeli biopharmaceutical and drug development companies combine life science knowhow with the spirit of entrepreneurship to provide a pipeline of many potential highly profitable treatments
• Israel's Medical Device Sector – A Magnet for Overseas Investment.
  Israel’s innovative medical device sector reflects the country's inter-disciplinary capabilities in medicine, electronics and IT.
• Digital Healthcare Promotes Prevention and Enhances Drug Discovery
  Israel's capabilities in big data, AI and machine learning are transforming horizons in biopharmaceuticals and healthcare.
• Noteworthy Recent Cases for Life Science Patent Owners
  By Mark Cohen, Senior Partner, Chair Life Science Practice Group, and Jonathan Passner, Partner Pearl Cohen Zedek Latzer Baratz.